Freemont Management’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,500
Closed -$68K 115
2022
Q3
$68K Buy
10,500
+771
+8% +$4.99K 0.01% 127
2022
Q2
$46K Hold
9,729
0.01% 131
2022
Q1
$68K Buy
+9,729
New +$68K 0.01% 132